Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Oxford Instruments plc
  6. News
  7. Summary
    OXIG   GB0006650450

OXFORD INSTRUMENTS PLC

(OXIG)
  Report
Delayed Quote. Delayed London Stock Exchange - 12/06 11:35:25 am
2360 GBX   +0.85%
12:02pOXFORD INSTRUMENTS : Notification of Major Holdings BlackRock 03/12
PU
10:32aOXFORD INSTRUMENTS PLC - Holding(s) in Company
PR
12/02OXFORD INSTRUMENTS PLC : Ex-dividend day for interim dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Oxford Instruments : Imaris launches Version 9.8

09/28/2021 | 09:22am EST

28 Sep

Imaris launches Version 9.8 Allowing Users to Better Analyse Large Volume Microscopy Datasets

Imaris, an Oxford Instruments brand, has today released Imaris 9.8, the latest version of its market-leading microscopy image analysis software.

In the latest release, we added object visualisation on extended sections, together with the raw data which opens new ways of validating detection and editing in Imaris. Now, users can clearly see the precision of the Spots and Surfaces detection, even in a "cluttered" data volume with thousa nds of objects. These features build upon the previous improvements for the most widely used image analysis models, Spots and Surfaces, for big data analysis and smooth interaction.

Anyone who has ever traced neurons within datasets where dendrites are overlapping and occluding one another in the 3D space knows that tracing validation is an almost impossible task in the 3D view. In Imaris 9.8, neurons can also be presented together with the raw data on the 2D slice view. In addition, the section thickness and orientation can be freely adjusted in any direction in 3D, including oblique orientations.

This is not the only benefit Imaris 9.8 offers for neuroscientists, as the well-known Filament Tracer model is enriched with soma detection and modelling, which adds important cell body statistics and branching classification.

Disclaimer

Oxford Instruments plc published this content on 28 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 September 2021 13:21:06 UTC.


© Publicnow 2021
All news about OXFORD INSTRUMENTS PLC
12:02pOXFORD INSTRUMENTS : Notification of Major Holdings BlackRock 03/12
PU
10:32aOXFORD INSTRUMENTS PLC - Holding(s) in Company
PR
12/02OXFORD INSTRUMENTS PLC : Ex-dividend day for interim dividend
FA
11/29OXFORD INSTRUMENTS : NanoScience Supports Ground-breaking Work in…
PU
11/24OXFORD INSTRUMENTS : Sir Martin Wood, 1927 - 2021
PU
11/24OXFORD INSTRUMENTS : Notification of Major Holdings BlackRock 23/11
PU
11/22OXFORD INSTRUMENTS : WITec Paper Award 2021 recognizes three outstanding publications
PU
11/22OXFORD INSTRUMENTS : WITec ParticleScout™ Enhanced with New Features
PU
11/22IMAGING ENHANCED : Today´s Raman Microscopy Applications
PU
11/22OXFORD INSTRUMENTS : WITec GmbH joins Oxford Instruments plc
PU
More news
Analyst Recommendations on OXFORD INSTRUMENTS PLC
More recommendations
Financials
Sales 2022 350 M 464 M 464 M
Net income 2022 41,9 M 55,6 M 55,6 M
Net cash 2022 72,9 M 96,7 M 96,7 M
P/E ratio 2022 31,9x
Yield 2022 0,78%
Capitalization 1 359 M 1 801 M 1 803 M
EV / Sales 2022 3,67x
EV / Sales 2023 3,47x
Nbr of Employees 1 619
Free-Float 93,9%
Chart OXFORD INSTRUMENTS PLC
Duration : Period :
Oxford Instruments plc Technical Analysis Chart | OXIG | GB0006650450 | MarketScreener
Technical analysis trends OXFORD INSTRUMENTS PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 2 360,00 GBX
Average target price 2 579,29 GBX
Spread / Average Target 9,29%
EPS Revisions
Managers and Directors
Ian Richard Barkshire Chief Executive Officer & Executive Director
Gavin Fenton Hill CFO, Group Finance Director & Executive Director
Neil Andrew Patrick Carson Non-Executive Chairman
Richard Henry Friend Independent Non-Executive Director
Mary Waldner Independent Non-Executive Director